Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2017 1
2018 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Page 1
m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study.
Grasa E, Seppälä J, Alonso-Solis A, Haapea M, Isohanni M, Miettunen J, Caro Mendivelso J, Almazan C, Rubinstein K, Caspi A, Unoka Z, Farkas K, Usall J, Ochoa S, van der Graaf S, Jewell C, Triantafillou A, Stevens M, Reixach E, Berdun J; m-RESIST group; Corripio I. Grasa E, et al. JMIR Form Res. 2023 Jun 30;7:e46179. doi: 10.2196/46179. JMIR Form Res. 2023. PMID: 37389933 Free PMC article.
Is intensive home-treatment a real alternative to classical hospitalization for managing acute psychiatric processes? Insights from clinical practice.
Martín-Blanco A, Calvo-Saiz L, Baccarin J, González-Fernández A, Keymer-Gausset A, Vieira-Costa S, Ribas-Fitó N, Garcia-Ribera C. Martín-Blanco A, et al. Among authors: keymer gausset a. Rev Psiquiatr Salud Ment (Engl Ed). 2022 Jul-Sep;15(3):213-215. doi: 10.1016/j.rpsmen.2022.09.009. Rev Psiquiatr Salud Ment (Engl Ed). 2022. PMID: 36272741 No abstract available.
Mobile therapeutic attention for treatment-resistant schizophrenia (m-RESIST): a prospective multicentre feasibility study protocol in patients and their caregivers.
Alonso-Solís A, Rubinstein K, Corripio I, Jaaskelainen E, Seppälä A, Vella VA, Caro-Mendivelso J, Caspi A, Isohanni M, Unoka Z, Van der Graff S, Farkas K, Huerta-Ramos E, Marcó-García S, Stevens M, Coenen T, Hospedales M, Berdún J; m-Resist group; Grasa EM. Alonso-Solís A, et al. BMJ Open. 2018 Jul 16;8(7):e021346. doi: 10.1136/bmjopen-2017-021346. BMJ Open. 2018. PMID: 30012788 Free PMC article.
Cognitive predictors of illness course at 12 months after first-episode of depression.
Vicent-Gil M, Keymer-Gausset A, Serra-Blasco M, Carceller-Sindreu M, de Diego-Adeliño J, Trujols J, Mur M, Pérez V, Alvarez E, Cardoner N, Portella MJ. Vicent-Gil M, et al. Among authors: keymer gausset a. Eur Neuropsychopharmacol. 2018 Apr;28(4):529-537. doi: 10.1016/j.euroneuro.2018.02.001. Epub 2018 Feb 23. Eur Neuropsychopharmacol. 2018. PMID: 29482974
Altered amplitude of low frequency fluctuations in schizophrenia patients with persistent auditory verbal hallucinations.
Alonso-Solís A, Vives-Gilabert Y, Portella MJ, Rabella M, Grasa EM, Roldán A, Keymer-Gausset A, Molins C, Núñez-Marín F, Gómez-Ansón B, Alvarez E, Corripio I. Alonso-Solís A, et al. Among authors: keymer gausset a. Schizophr Res. 2017 Nov;189:97-103. doi: 10.1016/j.schres.2017.01.042. Epub 2017 Jan 28. Schizophr Res. 2017. PMID: 28139359
[Olanzapine long-acting post-injection syndrome: a case report and brief review].
Duran-Sindreu SF, Grasa-Bello E, Corripio-Collado I, Sauras-Quetcuti RB, Keymer-Gausset A, Roldán-Bejarano A, Alonso-Solís A, Figueras-Vilalta M, Álvarez-Martínez E. Duran-Sindreu SF, et al. Among authors: keymer gausset a. Actas Esp Psiquiatr. 2013 Jan-Feb;41(1):60-2. Epub 2013 Jan 1. Actas Esp Psiquiatr. 2013. PMID: 23440537 Free article. Spanish.